Disclaimer:
Medidex is not a provider of medical services and all information is provided for the convenience of the user. No medical decisions should be made based on the information provided on this website without first consulting a licensed healthcare provider.This website is intended for persons 18 years or older. No person under 18 should consult this website without the permission of a parent or guardian.
Tri-Mili
Overview
What is Tri-Mili?
Tri-Mili is a combination oral contraceptive containing the progestational compound norgestimate and the estrogenic compound ethinyl estradiol. Norgestimate is designated as (18,19-Dinor-17-pregn-4-en-20-yn-3-one,17-(acetyloxy)-13-ethyl-, oxime,(17α)-(+)-) and ethinyl estradiol is designated as (19-nor-17α-pregna,1,3,5(10)-trien-20-yne-3,17-diol).
Each active white tablet contains 0.180 mg of norgestimate USP and 0.035 mg of ethinyl estradiol USP. Inactive ingredients include croscarmellose sodium, hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol, and titanium dioxide.
Each active light blue tablet contains 0.215 mg of norgestimate USP and 0.035 mg of ethinyl estradiol USP. Inactive ingredients include croscarmellose sodium, FD&C #2/Indigo carmine aluminum lake, hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol, and titanium dioxide.
Each active dark blue tablet contains 0.250 mg of norgestimate USP and 0.035 mg of ethinyl estradiol USP. Inactive ingredients include croscarmellose sodium, FD&C #2/Indigo carmine aluminum lake, hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol, and titanium dioxide.
Each green tablet contains only inert ingredients, as follows: anhydrous lactose, FD&C Blue No. 2 aluminum lake, ferric oxide yellow, magnesium stearate, microcrystalline cellulose, and povidone.
What does Tri-Mili look like?







What are the available doses of Tri-Mili?
Tri-Mili consists of 28 round, biconvex tablets in the following order ():
What should I talk to my health care provider before I take Tri-Mili?
Nursing mothers: Not recommended; can decrease milk production. ()
How should I use Tri-Mili?
Tri-Mili tablets are indicated for use by females of reproductive potential to prevent pregnancy .
Tri-Mili is available in blister pack . Tri-Mili may be started using either a Day 1 start or a Sunday start (see Table 1). For the first cycle of a Sunday Start regimen, an additional method of contraception should be used until after the first 7 consecutive days of administration.
What interacts with Tri-Mili?
Sorry No Records found
What are the warnings of Tri-Mili?
Sorry No Records found
What are the precautions of Tri-Mili?
Sorry No Records found
What are the side effects of Tri-Mili?
Sorry No records found
What should I look out for while using Tri-Mili?
Do not prescribe Tri-Mili to women who are known to have the following conditions:
Cigarette smoking increases the risk of serious cardiovascular events from combination oral contraceptive (COC) use. This risk increases with age, particularly in women over 35 years of age, and with the number of cigarettes smoked. For this reason, COCs are contraindicated in women who are over 35 years of age and smoke
What might happen if I take too much Tri-Mili?
There have been no reports of serious ill effects from overdosage of oral contraceptives, including ingestion by children. Overdosage may cause withdrawal bleeding in females and nausea.
How should I store and handle Tri-Mili?
TREMFYA is sterile and preservative-free. Discard any unused portion.Keep out of reach of children.TREMFYA is sterile and preservative-free. Discard any unused portion.Keep out of reach of children.Product: 50090-1970Product: 50090-2212NDC: 50090-2212-0 30 CAPSULE, DELAYED RELEASE in a BOTTLENDC: 50090-2212-1 90 CAPSULE, DELAYED RELEASE in a BOTTLEProduct: 50090-1970Product: 50090-2212NDC: 50090-2212-0 30 CAPSULE, DELAYED RELEASE in a BOTTLENDC: 50090-2212-1 90 CAPSULE, DELAYED RELEASE in a BOTTLEProduct: 50090-1970Product: 50090-2212NDC: 50090-2212-0 30 CAPSULE, DELAYED RELEASE in a BOTTLENDC: 50090-2212-1 90 CAPSULE, DELAYED RELEASE in a BOTTLEProduct: 50090-1970Product: 50090-2212NDC: 50090-2212-0 30 CAPSULE, DELAYED RELEASE in a BOTTLENDC: 50090-2212-1 90 CAPSULE, DELAYED RELEASE in a BOTTLE